Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec 1;12(6):949-952.
doi: 10.21037/hbsn-23-542. Epub 2023 Nov 9.

Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population

Josh Bilson  1   2 , Christopher D Byrne  1   2
Affiliations
Editorial

Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population

Josh Bilson et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Fatty liver disease (FLD); age; elderly; metabolic dysfunction steatotic liver disease (MASLD); metabolic dysfunction-associated fatty liver disease (MAFLD); mortality; non-alcoholic fatty liver disease (NAFLD); older population.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-542/coif). C.D.B. reports that he has received an independent research grant from Echosens who make Fibroscanners that are used to test for liver fibrosis since 1st Sep 2023, outside the submitted work. The other author has no conflicts of interest to declare.

Comment on

Similar articles

See all similar articles

References

    1. Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol 2021;6:578-88. 10.1016/S2468-1253(21)00020-0 - DOI - PubMed
    1. Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol 2015;62:S47-64. 10.1016/j.jhep.2014.12.012 - DOI - PubMed
    1. European Association for the Study of the Liver . EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol 2021;75:659-89. 10.1016/j.jhep.2021.05.025 - DOI - PubMed
    1. National Guideline Centre (UK). NICE Guideline, No. 49. Non-Alcoholic Fatty Liver Disease: Assessment and Management. London: National Institute for Health and Care Excellence (NICE), 2016. - PubMed
    1. Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103:2263-71. 10.1111/j.1572-0241.2008.02034.x - DOI - PMC - PubMed
-